首页 产品 解决方案 核心技术 学术论文 关于我们 产品咨询
English Français Deutsch Español Italiano Português Bahasa Indonesia 中文 繁體中文(香港) Русский 日本語 한국어 العربية Tiếng Việt ไทย

学术论文

汇集病理基础模型、图像分析与临床应用研究成果。

成果发表于:Nature Machine Intelligence · IEEE TMI · NeurIPS · CVPR · ICLR

精选团队论文及相关临床文献。

精选研究

重点论文

团队与合作研究者发表的同行评议论文。

D-PathAI相关临床研究

选读乳腺癌领域已通过同行评议的临床研究,了解D-PathAI在研究中的用途、主要结果与局限。

期刊论文 西湖大学共同署名

HER2-LADDER:HER2 阳性乳腺癌治疗反应预测研究

Wu et al. · Signal Transduction and Targeted Therapy 11, 241 (2026)

发表于 2026 年 6 月 19 日

研究结合治疗前活检的H&E、HER2 IHC切片及临床资料,建立研究用评分,预测患者接受新辅助双靶向抗HER2治疗后能否达到病理完全缓解。

研究设计 & 研究局限
研究设计
研究基于复旦大学附属肿瘤医院276例病例建立模型,并在三个队列中验证:时序验证队列82例、来自临床试验的验证队列85例,以及重庆外部验证队列40例。
D-PathAI 的作用
研究采用定制的D-PathAI分析流程,测量肿瘤细胞HER2膜染色的强度与完整性;H&E图像由HoVer-Net分析,再由研究团队建立的模型整合相关特征。
研究局限
回顾性分析可能存在选择偏倚。作者指出,在更广泛的临床应用前,仍需开展前瞻性验证,并统一染色与扫描流程。
期刊论文 外部临床研究

HER2判读一致性:研究结果与局限

Dong et al. · npj Breast Cancer 12, 9 (2026)

首次发表于 2025 年 12 月 9 日;正式版本日期为 2026 年 1 月 12 日

研究使用HER2 IHC切片及判读评分,评价染色结果的可重复性、不同阅片者评分的一致性,以及阅片者评分与共识评分的符合程度。

研究设计 & 研究局限
研究设计
研究对中国医科大学附属第一医院的1,455例病例进行了回顾性分析,并评价45家实验室的染色情况;另选209张切片,比较人工判读与AI辅助判读。
D-PathAI 的作用
在209张切片的比较中,D-PathAI用于辅助HER2 IHC判读。该组数据中,AI辅助判读获得了更高的一致性。
研究局限
研究仍发现细胞检测错误及非特异性染色干扰,HER2超低表达与零表达也未能可靠区分,结果仍需人工核查。

以上结果是在论文所述研究条件下取得的,不能直接代表所有现售模块、扫描仪及部署方式的性能。实际应用仍须结合具体产品配置和预期用途单独评估。

论文库

按研究主题浏览,或检索论文标题、作者、期刊与会议。

基础模型

研究大规模病理基础模型对图像块、全切片图像及病理报告的理解能力,涵盖多模态与生成式方法。

NeurIPS

CPathAgent: An Agent-based Foundation Model for Interpretable High-Resolution Pathology Image Analysis Mimicking Pathologists' Diagnostic Logic

会议论文 西湖大学共同署名

Sun, Y., Si, Y., Zhu, C., Zhang, K., Shui, Z., Ding, B., Lin, T., Yang, L. · NeurIPS 2025 · 2025

NeurIPS

PathVQ: Reforming Computational Pathology Foundation Model for Whole Slide Image Analysis via Vector Quantization

会议论文 西湖大学共同署名

Li, H., Shui, Z., Zhang, Y., Zhu, C., Yang, L. · NeurIPS 2025 · 2025

TMI

ToPoFM: Topology-Guided Pathology Foundation Model for High-Resolution Pathology Image Synthesis with Cellular-Level Control

Li, J., Zhu, C., Zheng, S., Chen, P., Sun, Y., Li, H., Yang, L. · IEEE Trans. Medical Imaging · 2025

CVPR

CPath-Omni: A Unified Multimodal Foundation Model for Patch and Whole Slide Image Analysis in Computational Pathology

Sun, Y., Si, Y., Zhu, C., Gong, X., Zhang, K., Chen, P., Zhang, Y., Shui, Z., Lin, T., Yang, L. · CVPR 2025 (CCF-A) · 2025

ICLR

PathGen-1.6M: 1.6 Million Pathology Image-text Pairs Generation through Multi-agent Collaboration

Sun, Y., Zhang, Y., Si, Y., Zhu, C., Zhang, K., Shui, Z., Li, J., Gong, X., Lyu, X., Lin, T., Yang, L. · ICLR 2025 (Oral) · 2025

AAAI

PathAsst: A Generative Foundation AI Assistant towards Artificial General Intelligence of Pathology

Sun, Y., Zhu, C., Zheng, S., Zhang, K., Sun, L., Shui, Z., Zhang, Y., Li, H., Yang, L. · AAAI 2024 (CCF-A, Oral) · 2024

ECCV

WSI-VQA: Interpreting Whole Slide Images by Generative Visual Question Answering

Chen, P., Zhu, C., Zheng, S., Li, H., Yang, L. · ECCV 2024 (CCF-A) · 2024

ACM MM

PathUp: Patch-wise Timestep Tracking for Multi-class Large Pathology Image Synthesising Diffusion Model

Li, J., Zheng, S., Zhu, C., Sun, Y., Chen, P., Shui, Z., Zhang, Y., Li, H., Yang, L. · ACM MM 2024 (CCF-A, Oral) · 2024

MICCAI

WSICaption: Multiple Instance Generation of Pathology Reports for Gigapixel Whole-Slide Images

Chen, P., Li, H., Zhu, C., Zheng, S., Shui, Z., Yang, L. · MICCAI 2024 (CCF-B, Oral) · 2024

应用研究

收录针对具体病理任务的方法研究、团队合作成果及外部临床文献。

STTT

Spatially interpretable artificial intelligence framework to tailored neoadjuvant dual HER2 blockade in HER2-positive breast cancer

期刊论文 西湖大学共同署名 临床研究 HER2 D-PathAI 新辅助治疗

Wu, X.-R., Lv, H., Zhao, S., Zeng, X.-H., Dai, L.-J., Xu, Y.-Z., Li, Y.-W., Qiu, Z.-Y., Huang, J.-T., Zhang, N.-N., Chen, L., He, M., Zhao, Y.-Z., Yang, L., Zhou, T., Li, J.-J., Wu, J., Jiang, Y.-Z., Yang, W.-T., Di, G.-H., Shao, Z.-M., Ma, D. · Signal Transduction and Targeted Therapy · 2026

npj Breast

HER2-low and ultralow expression of invasive breast carcinoma: clinicopathological features and immunohistochemical consistency analysis

期刊论文 外部临床研究 使用D-PathAI 临床研究 HER2 IHC AI辅助评分

Dong, Y.-h., Xu, Y.-t., Jiang, X.-z., Xu, L., Yu, R.-j., Wang, R., Zhang, Q.-f. · npj Breast Cancer · 2026

USCAP

Differentiation Between HER2 Ultra-Low and HER2 Null Breast Cancers Using an AI Support Tool: A Multi-Site Study

会议摘要 外部临床参考 临床研究 HER2超低表达 IHC 多中心研究

Grinwald, M., Schnitt, S., Vincent-Salomon, A., et al. · USCAP 2025 · Abstract 156 · 2025

USCAP

Artificial Intelligence Assisted Assessment of HER2-ultralow and HER2-low Immunohistochemical Scoring in Breast Cancer Core Needle Biopsy Specimens

会议摘要 外部临床参考 临床研究 HER2 IHC 粗针穿刺活检

Li, M., Cai, M., Lv, H., Zhou, S., Lin, M., Shui, R., Yang, W. · USCAP 2024 · Abstract 178 · 2024

SABCS

The Advantage of Artificial-Intelligence in HER2 IHC 0 and 1+ Scoring in Breast Cancer

壁报摘要 西湖大学共同署名 临床研究 HER2 IHC AI评分

Li, M., Lv, H., Zhao, Y., Zhu, C., Li, H., Lin, M., Yang, W. · SABCS 2023 · Cancer Research 84(9 Suppl.), PO4-26-09 · 2024

AAAI

Towards Effective and Efficient Context-aware Nucleus Detection in Histopathology Whole Slide Images

会议论文 西湖大学共同署名

Shui, Z., Li, H., Zhang, Y., Sun, Y., Ye, Y., Chen, P., Guo, R., Cui, L., Zhu, C., Yang, L. · AAAI 2026 · 2026

PLOS One

Weakly supervised deep multi-instance learning for classification of endometrial lesions on hematoxylin and eosin-stained whole-slide images

期刊论文 西湖大学共同署名

Zhou, Z., Guo, J., Du, X., Li, H., Xie, N., Liu, C., He, H., Yang, L., Cui, L., Fu, C. · PLOS One · 2026

MICCAI

AEM: Attention Entropy Maximization for Multiple Instance Learning based Whole Slide Image Classification

会议论文 西湖大学共同署名

Zhang, Y., Li, H., Sun, Y., Shui, Z., Li, J., Zhu, C., Yang, L. · MICCAI 2025 · 2025

Allergy

Artificial Intelligence-Based Pathological Subtype Diagnosis of Nasal Polyps: A Multidimensional and Micro-Visualization Study

临床研究 鼻息肉

Luo, X., Li, H., Chen, J., Zhou, Z., Zhou, L., Luo, R., ..., Cui, L., Yang, L., Yang, Q. · Allergy · 2026

ICASSP

Stable Test-Time Training for Semantic Segmentation with Output Contrastive Loss

Zhang, Y., Shui, Z., Li, H., Sun, Y., Zhu, C., Yang, L. · ICASSP 2025 (CCF-B) · 2025

Cancer Cell

Spatial determinants of antibody-drug conjugate SHR-A1811 efficacy in neoadjuvant treatment for HER2-positive breast cancer

临床研究 HER2 新辅助治疗

Ma, D., Dai, L.-J., Wu, X.-R., Liu, C.-L., Zhao, S., Zhang, H., Chen, L., Xiao, Y., Li, M., Zhao, Y.-Z., ... · Cancer Cell · 2025

ECCV

Attention-Challenging Multiple Instance Learning for Whole Slide Image Classification

Zhang, Y., Li, H., Sun, Y., Zheng, S., Zhu, C., Yang, L. · ECCV 2024 (CCF-A) · 2024

ECCV

Unleashing the Power of Prompt-Driven Nucleus Instance Segmentation

Shui, Z., Zhang, Y., Yao, K., Zhu, C., Zheng, S., Li, J., Li, H., Sun, Y., Guo, R., Yang, L. · ECCV 2024 (CCF-A) · 2024

NeurIPS

Rethinking Transformer for Long Contextual Histopathology Whole Slide Image Analysis

Li, H., Zhang, Y., Chen, P., Shui, Z., Zhu, C., Yang, L. · NeurIPS 2024 (CCF-A) · 2024

AAAI

DPA-P2PNet: Deformable Proposal-Aware P2PNet for Accurate Point-Based Cell Detection

Shui, Z., Zheng, S., Zhu, C., Zhang, S., Yu, X., Li, H., Li, J., Chen, P., Yang, L. · AAAI 2024 (CCF-A) · 2024

Neural Net.

Gradient-Aware Learning for Joint Biases: Label Noise and Class Imbalance

Zhang, S., Zhu, C., Li, H., Cai, J., Yang, L. · Neural Networks · 2024

CSBJ

Performance of a HER2 Testing Algorithm Tailored for Urothelial Bladder Cancer: A Bi-centre Study

临床研究 HER2 IHC

Huang, A., Zhao, Y., Guan, F., Zhang, H., ... · Computational and Structural Biotechnology Journal · 2024

ICME

Context-Aware Text-Assisted Multimodal Framework for Cervical Cytology Cell Diagnosis and Chatting

临床研究 TCT 宫颈细胞学

Sun, Y., Zhu, C., Zheng, S., Zhang, Y., Li, H., Yang, L. · ICME 2024 (CCF-B) · 2024

ICASSP

HLS-FGVC: Hierarchical Label Semantics Enhanced Fine-Grained Visual Classification

Zhang, S., Zheng, S., Shui, Z., Yang, L. · ICASSP 2024 (CCF-B) · 2024

BIBM

Multi-modal Learning with Missing Modality in Predicting Axillary Lymph Node Metastasis

Zhang, S., Zheng, S., Shui, Z., Li, H., Yang, L. · BIBM 2023 (CCF-B) · 2023

CVPR

Task-specific Fine-tuning via Variational Information Bottleneck for Weakly-supervised Pathology WSI Classification

Li, H., Zhu, C., Zhang, Y., Sun, Y., Shui, Z., Kuang, W., Zheng, S., Yang, L. · CVPR 2023 (CCF-A) · 2023

MICCAI

Segment Membranes and Nuclei from Histopathological Images via Nuclei Point-Level Supervision

临床研究 IHC 细胞膜分割

Li, H., Xu, Z., Zhou, M., Shi, X., Kang, Y., Bu, Q., Lv, H., Li, M., Lin, M., Cui, L., Feng, J., Yang, W., Yang, L. · MICCAI 2023 (CCF-B) · 2023

TMI

Masked Conditional Variational Autoencoders for Chromosome Straightening

Li, J., Zheng, S., Shui, Z., Zhang, S., Yang, L., Sun, Y., Zhang, Y., Li, H., ... · IEEE Trans. Medical Imaging · 2023

MICCAI

Exploring Unsupervised Cell Recognition with Prior Self-Activation Maps

Chen, P., Zhu, C., Shui, Z., Cai, J., Zheng, S., Zhang, S., Yang, L. · MICCAI 2023 (CCF-B) · 2023

MICCAI

End-to-End Cell Recognition by Point Annotation

Shui, Z., Zhang, S., Zhu, C., Wang, B., Chen, P., Zheng, S., Yang, L. · MICCAI 2022 (CCF-B) · 2022

MICCAI

ChrsNet: Chromosome Straightening Using Self-Attention Guided Networks

Zheng, S., Li, J., Shui, Z., Zhu, C., Zhang, Y., Chen, P., Yang, L. · MICCAI 2022 (CCF-B) · 2022

ISBI

Weakly Supervised Learning for Cell Recognition in Immunohistochemical Cytoplasm Staining Images

临床研究 IHC

Zhang, S., Zhu, C., Li, H., Cai, J., Yang, L. · ISBI 2022 · 2022

ISBI

Category Separation For Weakly Supervised Multi-Class Cell Counting

Cai, J., Zhu, C., Chen, P., Zhang, S., Li, H., Sun, Y., Yang, L. · ISBI 2022 · 2022

ISBI

Weakly Supervised Classification Using Multi-Level Instance-Aware Optimization on Cervical Cytologic Image

临床研究 TCT

Zhu, C., Sun, Y., Li, H., Cui, C., Zhang, S., Cai, J., Ling, Y. · ISBI 2022 · 2022

MICCAI

Generalizing Nucleus Recognition Model in Multi-Source Ki67 Immunohistochemistry Stained Images via Domain-Specific Pruning

临床研究 IHC Ki67

Cai, J., Zhu, C., Cui, C., Li, H., Wu, T., Zhang, S., Yang, L. · MICCAI 2021 (CCF-B) · 2021

J. Transl. Med.

Automated Tumor Proportion Scoring for PD-L1 Expression Based on Multistage Ensemble Strategy in NSCLC

临床研究 PD-L1 IHC

Pan, B., Kang, Y., Jin, Y., Yang, L., Zheng, Y., Cui, L., Sun, J., Feng, J., Li, Y., Guo, L., Liang, Z. · J. Translational Medicine · 2021

AI Med.

Rule-based automatic diagnosis of thyroid nodules from intraoperative frozen sections using deep learning

临床研究 冰冻切片 甲状腺

Li, Y., Chen, P., Li, Z., Su, H., Yang, L., Zhong, D. · Artificial Intelligence in Medicine · 2020

Nature Mach. Intell.

Pathologist-level Interpretable Whole-slide Cancer Diagnosis with Deep Learning

Zhang, Z., Chen, P., McGough, M., ..., Cui, L., ..., Yang, L. · Nature Machine Intelligence · 2019

基准测试

评测病理AI在图像块及全切片分析中的表现,研究模型的鲁棒性。

TMI

PathBench: Advancing the Benchmark of Large Multimodal Models for Pathology Image Understanding at Patch and Whole Slide Level

Sun, Y., Wu, H., Zhu, C., Si, Y., Chen, Q., Zhang, Y., Zhang, K., Li, J., Cai, J., Wang, Y., ... · IEEE Trans. Medical Imaging · 2025

ECCV

PathMMU: A Massive Multimodal Expert-Level Benchmark for Understanding and Reasoning in Pathology

Sun, Y., Wu, H., Zhu, C., Zheng, S., Chen, Q., Zhang, K., Zhang, Y., Wan, D., Lan, X., ... · ECCV 2024 (CCF-A, Oral) · 2024

JIIM

Benchmarking PathCLIP for Pathology Image Analysis

Zheng, S., Cui, X., Sun, Y., Li, J., Li, H., Zhang, Y., Chen, P., Jing, X., Ye, Z., Yang, L. · J. Imaging Informatics in Medicine · 2024

ICASSP

Assessing the Robustness of Deep Learning-Assisted Pathological Image Analysis Under Practical Variables of Imaging System

Sun, Y., Zhu, C., Zhang, Y., Li, H., Chen, P., Yang, L. · ICASSP 2023 (CCF-B) · 2023

MICCAI

Benchmarking the Robustness of Deep Neural Networks to Common Corruptions in Digital Pathology

Zhang, Y., Sun, Y., Li, H., Zheng, S., Zhu, C., Yang, L. · MICCAI 2022 (CCF-B) · 2022

图片预览

—

正在载入图片…